Aster Capital Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Other funds holding IMVT
Aster Capital Management's IMVT Position: Q3 2026 in Review
Aster Capital Management opened a new position in Immunovant (IMVT) in Q3 2026: 206 shares worth $6.96K. The stake represents ﹤0.01% of the portfolio and ranks #811 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in IMVT as recently as Q3 2025.
Aster Capital Management first reported a position in IMVT in Q3 2024 and has held it in 4 quarters since. The position peaked at $33.2K in Q3 2025. 232 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.
- Aster Capital Management held 206 shares of Immunovant worth $6.96K as of Q3 2026.
- Immunovant was a new Aster Capital Management position in Q3 2026.
- Immunovant made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #811 holding.
- Aster Capital Management first reported a position in Immunovant in Q3 2024 and has held it in 4 quarters since.
- Aster Capital Management's Immunovant position peaked at $33.2K in Q3 2025.
- 232 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.